| #1 | | | Istanbul, Turkey | | 29+ years | Immunotherapy, targeted therapy, systemic chemotherapy | HER2-negative and aggressive breast cancer | Clinic offers multidisciplinary tumor board reviews with ESMO-certified specialists. Uses immunotherapy combined with PET-CT staging for personalized treatment plans. Affiliated with Johns Hopkins Medicine. | International Organization for Standardization, Joint Commission International |
| #2 | | | Istanbul, Turkey | | 12+ years | MRI of one area, Biochemical blood analysis | — | — | Turkish Medical Association, International Health Tourism Authorization Certificate |
| #3 | | | Milan, Italy | | 57+ years8,000+ treatments | Immunotherapy for breast cancer, clinical trials for immunotherapies | Breast cancer with immune system involvement | Head of breast cancer group leads immunotherapy research, with over 100 clinical trials conducted. 12,000 cancer patients treated annually, including complex breast cancer cases. | Scientific Institute for Research and Healthcare Accrediatation, World's Best Hospitals 2021 by Newsweek |
| #4 | | | Barcelona, Spain | | 41+ years23,000+ treatments | Immunotherapy for breast cancer, checkpoint inhibitors (atezolizumab, pembrolizumab), combination therapies, clinical trial evaluations | Personalized breast cancer immunotherapy | Led by Dr. Agusti Barnadas Molins, a specialist with 35+ years in breast cancer and over 130 publications. The clinic offers advanced diagnostics like PD-L1 and TMB testing, and provides personalized treatment plans based on tumor genetics. | Joint Commission International , European Foundation for Quality Management |
| #5 | | | Vienna, Austria | | 44+ years | PET/CT | — | — | International Organization for Standardization, World's Best Hospitals 2021 by Newsweek |
| #6 | | | Istanbul, Turkey | | 26+ years | Immunotherapy, chemotherapy, targeted therapy, PET-CT for treatment evaluation | Metastatic breast cancer with wide dissemination | Follows international NCCN and ESMO protocols, offers personalized treatment plans with post-therapy PET-CT evaluation, and has a high patient recommendation rate of 91%. | International Organization for Standardization, Joint Commission International |
| #7 | | | Tel Aviv, Israel | | 41+ years34,000+ treatments | Immunotherapy, hormonal therapy, chemotherapy, biotherapy, radiotherapy, lumpectomy, mastectomy | Metastatic breast cancer patients | Achieves a 90% success rate in metastatic breast cancer treatment. Uses a multidisciplinary approach with advanced techniques like immunotherapy and genetic testing. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek |
| #8 | | | Istanbul, Turkey | | 21+ years | Scintigraphy, Consultation with a neurosurgeon | — | — | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) |
| #9 | | | Istanbul, Turkey | | 26+ years | Mammography, CT (computer tomography) | — | — | International Organization for Standardization, Joint Commission International |
| #10 | | | Hamburg, Germany | | 26+ years | CT (computer tomography), Gastroscopy with biopsy | — | — | International Organization for Standardization, Medical Travel Quality Alliance |